Importance of resectability status in neoadjuvant treatment for pancreatic cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1868-6982|22|7|563-570

ISSN： 1868-6974

Source： JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.22, Iss.7, 2015-07, pp. : 563-570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 8, 2015-06 ,pp. : 1028-1034

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre‐treatment carbohydrate antigen 19‐9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

By  

HPB, Vol. 17, Iss. 10, 2015-10 ,pp. : 942-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advances in the adjuvant and neoadjuvant treatment of breast cancer

By Briest Susanne   Stearns Vered  

Women's Health, Vol. 3, Iss. 3, 2007-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite

Neoadjuvant Hormonal Treatment and Radiotherapy for Prostate Cancer

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 29-33

Karger

Access to resources Recommend Favorite

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 64-70

Karger

Access to resources Recommend Favorite